drugset / Trial / NCT00544310

Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil

NCT00544310 ↗

Phase 1/2 Unknown 25 enrolled OMRIX Biopharmaceuticals
RandomizedSingle-groupDouble-blindPrevention

Summary

The objective is to evaluate the safety and initial efficacy of the Omrix Anti-Adhesion (AA) kit, Adhexil™ in preventing and/or reducing post-operative adhesions in patients undergoing surgery involving the ovaries.

Timeline

Start
2008-01
Primary completion
—
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ADHEXIL Unknown — —

Indications